Mc-MMAE

CAS No. 863971-24-8

Mc-MMAE( Maleimidocaproyl-monomethylauristatin E )

Catalog No. M26983 CAS No. 863971-24-8

Mc-MMAE is a drug-linker conjugate for ADC. Mc-MMAE is a maleimidocaproyl-conjugated monomethyl auristatin E, which is a potent tubulin inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 69 In Stock
5MG 123 In Stock
10MG 198 In Stock
25MG 345 In Stock
50MG 550 In Stock
100MG 918 In Stock
200MG 1237 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Mc-MMAE
  • Note
    Research use only, not for human use.
  • Brief Description
    Mc-MMAE is a drug-linker conjugate for ADC. Mc-MMAE is a maleimidocaproyl-conjugated monomethyl auristatin E, which is a potent tubulin inhibitor.
  • Description
    Mc-MMAE is a drug-linker conjugate for ADC. Mc-MMAE is a maleimidocaproyl-conjugated monomethyl auristatin E, which is a potent tubulin inhibitor.(In Vitro):The synthesis of Mc-MMAE requires the addition of maleimidohexanoic acid in a solution of monomethyl auristatin E in dichloromethane, followed by addition of diethyl cyanophosphonate and diisopropylethylamine .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Maleimidocaproyl-monomethylauristatin E
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Microtubule/Tubulin
  • Recptor
    IKKα
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    863971-24-8
  • Formula Weight
    911.195
  • Molecular Formula
    C49H78N6O10
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 180 mg/mL (197.55 mM)
  • SMILES
    CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN1C(=O)C=CC1=O)C(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Pletz N, et al. Doxorubicin-induced activation of NF-κB in melanoma cells is abrogated by inhibition of IKKβ, but not by a novel IKKα inhibitor. Exp Dermatol. 2012 Apr;21(4):301-4.
molnova catalog
related products
  • NSC639829

    A potent anticancer agent that demonstrates potent antitumor activity in vitro against several cancer cell lines.

  • Estramustine

    Estramustine is a nitrogen mustard linked to estradiol, usually as phosphate. Estramustine has been used to treat prostatic neoplasms; also has radiation protective properties.

  • VU 0364439

    VU 0364439 is a mGlu4 positive allosteric modulator (C50: 19.8 nM).